Some tumor biomarkers, such as carcinoembryonic antigen (CEA) and carbohydrate antigen-199 (CA199), are also used to diagnose CRC, but the diagnostic accuracy remain unsatisfactory and they were not recommended for CRC screening in current clinical guideline [6, 7]. The gene discussed is CEACAM5; the disease is neoplasm.